Life Sciences Tools and Services
Company Overview of NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc., a biotech company, offers gamma-secretase modulators for the prevention of Alzheimer’s disease. It provides NGP 555, a small molecule modulator of the gamma-secretase complex, which crosses the blood-brain barrier and is used in lowering the brain biomarkers Aß42 and Aß40 while showing an increase in the Aß38 peptide with no effect on Notch processing. NeuroGenetic Pharmaceuticals, Inc. was founded in 2009 and is based in Del Mar, California.
445 Marine View Avenue
Del Mar, CA 92014
Founded in 2009
Key Executives for NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact NeuroGenetic Pharmaceuticals, Inc., please visit www.neurogeneticpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.